Is Curcumin worth prioritizing?

A GRADE-assessed dose-response meta-analysis found curcumin supplementation reduces inflammatory and oxidative stress markers, an effect replicated across specific populations including people with chronic inflammatory diseases, metabolic syndrome, non-alcoholic fatty liver disease, and chronic kidney disease. Weighing that against the numbers, Curcumin is not a priority based on current data — the evidence is only moderate (58/100), and its estimated impact (40/100) is on the lower end too.